Description
Phosphorylated Tau231 (p-Tau231) has emerged as a crucial isoform and a core fluid biomarker for the diagnosis and staging of Alzheimer’s Disease. By enabling the identification of hallmark pathological features 10–20 years before clinical onset, our p-Tau231 detection kit serves as an essential tool for early intervention and therapeutic monitoring.
Key Features:
- Ultra-Sensitive Digital Detection: Powered by single-molecule digital immunoassay technology, delivering 1,000x greater sensitivity than traditional methods to detect trace proteins at the femtogram level.
- Enhanced Clinical Decision-Making: Specifically designed to help clinicians better understand and manage disease progression in affected patients through objective data.
- Advanced Double-Antibody Sandwich Assay: Utilizes magnetic beads coated with specific p-Tau231 capture antibodies and high-resolution fluorescence imaging for absolute accuracy.
- Patient-Centric Non-Invasive Testing: High-precision results obtained from simple human plasma samples, eliminating the need for invasive CSF collection.
- Seamless Laboratory Integration: Engineered for the Inspirer DX Analyzer, supporting a rapid 20-30 minute turnaround with only a 25 μL loading volume.
Technical Specifications:
- Generic Name: Human phosphorylated Tau231 protein detection kit (digital immunochip method).
- Packing Specs: 48 tests/box or 96 tests/box.
- Sample Type: Human Plasma.
- Limit of Detection: 2.5 fg/mL (System performance).
